Total Payments
$3,381
2022 Payments
$2,465
Companies
5
Transactions
21
Medicare Patients
1,247
Medicare Billing
$187,913
Payment Breakdown by Category
Travel$2,009 (59.4%)
Food & Beverage$1,372 (40.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,009 | 5 | 59.4% |
| Food and Beverage | $1,372 | 16 | 40.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $2,465 | 11 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $415.40 | 5 | $0 (2018) |
| GENZYME CORPORATION | $249.13 | 2 | $0 (2019) |
| Veloxis Pharmaceuticals, Inc. | $190.44 | 2 | $0 (2018) |
| Relypsa, Inc. | $60.43 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,465 | 11 | CSL Behring ($2,465) |
| 2019 | $124.94 | 1 | GENZYME CORPORATION ($124.94) |
| 2018 | $430.80 | 4 | Novartis Pharmaceuticals Corporation ($190.72) |
| 2017 | $359.66 | 5 | Novartis Pharmaceuticals Corporation ($224.68) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $1,010.26 | General |
| 08/19/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $166.44 | General |
| 08/19/2022 | CSL Behring | — | Travel and Lodging | Cash or cash equivalent | $54.00 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $113.87 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $104.69 | General |
| 08/18/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 08/17/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $611.45 | General |
| 08/17/2022 | CSL Behring | — | Travel and Lodging | In-kind items and services | $166.44 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $28.42 | General |
| 08/17/2022 | CSL Behring | — | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| 12/15/2019 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2018 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $67.81 | General |
| 06/03/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $122.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2018 | GENZYME CORPORATION | THYMOGLOBULIN (Drug) | Food and Beverage | In-kind items and services | $124.19 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $115.89 | General |
| Category: Immunosuppressant | ||||||
| 09/13/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $60.43 | General |
| Category: Hyperkalemia | ||||||
| 05/12/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2017 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $114.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2017 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $74.55 | General |
| Category: Immunosuppressant | ||||||
| 04/06/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $88.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 193 | 341 | $94,675 | $29,808 |
| 2022 | 6 | 286 | 563 | $151,624 | $45,820 |
| 2021 | 8 | 361 | 724 | $199,675 | $61,283 |
| 2020 | 11 | 407 | 666 | $173,308 | $51,003 |
Total Patients
1,247
Total Services
2,294
Medicare Billing
$187,913
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 66 | 202 | $46,460 | $17,296 | 37.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 56 | $28,000 | $6,716 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 26 | 28 | $6,860 | $1,674 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 16 | $5,600 | $1,642 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 24 | $4,080 | $1,401 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,675 | $1,079 | 29.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 298 | $68,540 | $22,573 | 32.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 62 | 70 | $36,100 | $9,852 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 62 | 88 | $21,970 | $6,225 | 28.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 73 | $12,730 | $3,851 | 30.2% |
| 99496 | Transitional care management services for problem of high complexity | Facility | 2022 | 17 | 17 | $9,349 | $2,470 | 26.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 15 | 17 | $2,935 | $850.04 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 126 | 450 | $103,500 | $34,528 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 84 | 91 | $47,775 | $13,412 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 66 | $16,830 | $4,545 | 27.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 17 | 17 | $8,500 | $2,082 | 24.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 36 | $6,480 | $1,940 | 29.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2021 | 12 | 12 | $6,599 | $1,786 | 27.1% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 13 | 24 | $5,090 | $1,566 | 30.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 28 | $4,900 | $1,424 | 29.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 105 | 312 | $71,760 | $24,499 | 34.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 51 | 58 | $30,450 | $8,540 | 28.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 85 | 97 | $24,735 | $5,162 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 55 | $9,900 | $3,091 | 31.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 15 | 15 | $7,500 | $1,962 | 26.2% |
About Dr. Eric Langewisch, M.D
Dr. Eric Langewisch, M.D is a Nephrology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366576662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Langewisch, M.D has received a total of $3,381 in payments from pharmaceutical and medical device companies, with $2,465 received in 2022. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($2,009).
As a Medicare-enrolled provider, Langewisch has provided services to 1,247 Medicare beneficiaries, totaling 2,294 services with total Medicare billing of $187,913. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Internal Medicine
- Location Omaha, NE
- Active Since 03/16/2007
- Last Updated 08/06/2016
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1366576662
Products in Payments
- ZORTRESS (Drug) $258.84
- THYMOGLOBULIN (Drug) $249.13
- Envarsus XR (SP) (Drug) $115.89
- Envarsus XR (Drug) $74.55
- Veltassa (Drug) $60.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Omaha
Richard Lund, M.d, M.D
Nephrology — Payments: $364,423
Nephrology $364,423
Dr. Jeffrey Passer, Md, MD
Nephrology — Payments: $119,054
Nephrology $119,054
Roslyn Mannon, M.d, M.D
Nephrology — Payments: $64,489
Nephrology $64,489
Dr. Stefan Hemmings, M.b., B.s, M.B., B.S
Nephrology — Payments: $4,386
Nephrology $4,386
Jerry Fischer, Md, Phd, MD, PHD
Nephrology — Payments: $3,680
Nephrology $3,680
Sunil Jagadesh, Md, MD
Nephrology — Payments: $3,648
Nephrology $3,648